Literature DB >> 7490538

Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.

S B Richardson1, T Laya, M VanOoy.   

Abstract

Vasopressin (VP) elicits almost identical insulin-stimulatory dose responses in isolated mouse islets and hamster beta (HIT) cells. We have further pharmacologically characterized HIT cell VP receptors by comparing the potencies of a series of VP agonists including the novel V1b agonist, desamino(D-3-(3'-pyridyl)-Ala2,Arg8)VP (d(D-3-Pal)VP), in stimulating insulin secretion and inositol phosphate (IP) production. The relative orders of potency of VP analogues were parallel in both respects: desamino-Arg-VP (dAVP) > Arg-vasotocin (AVT) = VP > oxytocin (OXY) > desamino-D-Arg-VP (dDAVP) > d(D-3-Pal)VP. dAVP, the most potent agonist tested, behaved as a V1 but non-V1a agonist. The potency of d(D-3-Pal)VP relative to VP was 1:134 in stimulating insulin secretion and 1:40 with respect to IP production. In HIT cell monolayers, the relative order of affinity of analogues in competition for binding with [3H]AVP was: dAVP > AVT = VP > V1a antagonist > OXY > dDAVP > V2 antagonist = d(D-3-Pal)VP, in parallel with their biological activity. The relative orders of potency and affinity parallel those reported for corticotrophic V1b receptors. Binding studies with hamster liver membranes indicate that the hepatic VP receptor belongs to the V1a class. We conclude that VP activates phospholipase C and interacts with functional VP receptors of the V1 type, which do not belong to the V1a subclass and which are similar to V1b receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490538     DOI: 10.1677/joe.0.1470059

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Insulin hypersensitivity in mice lacking the V1b vasopressin receptor.

Authors:  Yoko Fujiwara; Masami Hiroyama; Atsushi Sanbe; Toshinori Aoyagi; Jun-Ichi Birumachi; Junji Yamauchi; Gozoh Tsujimoto; Akito Tanoue
Journal:  J Physiol       Date:  2007-08-02       Impact factor: 5.182

Review 2.  Vasopressin: a novel target for the prevention and retardation of kidney disease?

Authors:  Lise Bankir; Nadine Bouby; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

3.  The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice.

Authors:  Antonia Sassmann; Belinda Gier; Hermann-Josef Gröne; Gisela Drews; Stefan Offermanns; Nina Wettschureck
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  TRPM4 controls insulin secretion in pancreatic beta-cells.

Authors:  Henrique Cheng; Andreas Beck; Pierre Launay; Stefan A Gross; Alexander J Stokes; Jean-Pierre Kinet; Andrea Fleig; Reinhold Penner
Journal:  Cell Calcium       Date:  2006-06-27       Impact factor: 6.817

5.  Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Yo Na Kim; Il Yong Kim; Son-Il Pak; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.